Showing results (221-230 of 259) with videos related to
Sort By:
Pageof 26
Research Square|May 20, 2021
Systems biological assessment of human immunity to BNT162b2 mRNA vaccinationPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.Biorxiv : the Preprint Server for Biology|August 2, 2024
Computationally designed mRNA-launched protein nanoparticle vaccinesGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.Immunity|April 3, 2026
Multiplexed antigen panel analysis identifies B cell phenotype and receptor genetic contributions to antibody breadthOliver F Wirz, Prasanti Kotagiri, Emily Haraguchi, et al.Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.Science Translational Medicine|October 15, 2025
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in miceGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.Nature Medicine|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S Arunachalam, Tysheena P Charles, Vineet Joag, et al.Allergy|July 21, 2024
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adultsMihir M Shah, Janice A Layhadi, Dennis E Hourcade, et al.Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.Cell Host & Microbe|December 3, 2021
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in MongoliaNaranjargal J Dashdorj, Oliver F Wirz, Katharina Röltgen, et al.Pageof 26